These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 626193)
1. Controlling thrombophlebitis from amphotericin B. Arbuthnot R; Dullea A; Rippel S Am J Hosp Pharm; 1978 Feb; 35(2):129. PubMed ID: 626193 [No Abstract] [Full Text] [Related]
2. Taking the terror out of amphotericin B. Mahon SM Am J Nurs; 1988 Jul; 88(7):960-4. PubMed ID: 3381848 [No Abstract] [Full Text] [Related]
3. Amphotericin B: effective management of adverse reactions. Anderson M; Faulkner N Cancer Nurs; 1982 Dec; 5(6):461-3. PubMed ID: 6924601 [No Abstract] [Full Text] [Related]
4. Compatibility of amphotericin B with drugs used to reduce adverse reactions. Gotz VP; Mar DD; Roche JJ Am J Hosp Pharm; 1981 Mar; 38(3):378-9. PubMed ID: 7223754 [No Abstract] [Full Text] [Related]
5. Pretreatment regimens for adverse events related to infusion of amphotericin B. Goodwin SD; Cleary JD; Walawander CA; Taylor JW; Grasela TH Clin Infect Dis; 1995 Apr; 20(4):755-61. PubMed ID: 7795069 [TBL] [Abstract][Full Text] [Related]
8. Clinical and serologic features of 47 patients with paracoccidioidomycosis treated by amphotericin B. de Campos EP; Sartori JC; Hetch ML; de Franco MF Rev Inst Med Trop Sao Paulo; 1984; 26(4):212-7. PubMed ID: 6522952 [No Abstract] [Full Text] [Related]
9. Drugs for the treatment of systemic fungal infections. Med Lett Drugs Ther; 1978 Jul; 20(15):66-8. PubMed ID: 661747 [No Abstract] [Full Text] [Related]
10. Amphotericin B: Ten common questions. Comer JB Am J Nurs; 1981 Jun; 81(6):1166-7. PubMed ID: 6909008 [No Abstract] [Full Text] [Related]
11. The clinical application of research utilization: amphotericin B. Reedy AM; Shivnan JC; Hanson JL; Haisfield ME; Gregory RE Oncol Nurs Forum; 1994 May; 21(4):715-9. PubMed ID: 8047470 [TBL] [Abstract][Full Text] [Related]
13. [Intravenous amphotericin B at home, why not?]. Fernández-Miera M; Fariñas Alvarez Mdel C; Hazas Feo MJ; Sanroma Mendizábal P Med Clin (Barc); 1994 Mar; 102(11):434-5. PubMed ID: 8183004 [No Abstract] [Full Text] [Related]
14. Severe thrombophlebitis with naftidrofuryl oxalate. Gann M Br Med J; 1977 Jun; 1(6076):1598. PubMed ID: 871682 [No Abstract] [Full Text] [Related]
15. Hyperkalemia associated with rapid infusion of conventional and lipid complex formulations of amphotericin B. Barcia JP Pharmacotherapy; 1998; 18(4):874-6. PubMed ID: 9692667 [TBL] [Abstract][Full Text] [Related]
16. Transient asystole associated with amphotericin B infusion. DeMonaco HJ; McGovern B Drug Intell Clin Pharm; 1983; 17(7-8):547-8. PubMed ID: 6347598 [TBL] [Abstract][Full Text] [Related]
17. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus. Späth-Schwalbe E; Koschuth A; Dietzmann A; Schanz J; Possinger K Clin Infect Dis; 1999 Mar; 28(3):680-1. PubMed ID: 10194097 [No Abstract] [Full Text] [Related]
18. [Pulmonary mucormycosis: benefit of aerosol amphotericin B?]. Furco A; Mouchet B; Carbonnelle M; Vallerand H Rev Mal Respir; 2001 Jun; 18(3):309-13. PubMed ID: 11468594 [TBL] [Abstract][Full Text] [Related]
19. Acrocyanosis developed with amphotericin B deoxycholate but not with amphotericin B lipid complex. Ozaras R; Yemisen M; Mete B; Mert A; Ozturk R; Tabak F Mycoses; 2007 May; 50(3):242. PubMed ID: 17472626 [No Abstract] [Full Text] [Related]
20. Amphotericin B therapy in kala-azar. Giri OP J Indian Med Assoc; 1993 Apr; 91(4):91-3. PubMed ID: 8409490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]